Advanced SearchSearch Tips
NMR Signal Assignments of Human Adenylate Kinase 1 (hAK1) and its R138A Mutant (hAK1R138A)
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
 Title & Authors
NMR Signal Assignments of Human Adenylate Kinase 1 (hAK1) and its R138A Mutant (hAK1R138A)
Kim, Gilhoon; Chang, Hwanbong; Won, Hoshik;
  PDF(new window)
Adenylate kinase (AK) enzyme which acts as the catalyst of reversible high energy phosphorylation reaction between ATP and AMP which associate with energetic metabolism and nucleic acid synthesis and signal transmission. This enzyme has three distinct domains: Core, AMP binding domain (AMPbd) and Lid domain (LID). The primary role of AMPbd and LID is associated with conformational changes due to flexibility of two domains. Three dimensional structure of human AK1 has not been confirmed and various mutation experiments have been done to determine the active sites. In this study, AK1R138A which is changed arginine[138] of LID domain with alanine[138] was made and conducted with NMR experiments, backbone dynamics analysis and mo-lecular docking dynamic simulation to find the cause of structural change and substrate binding site. Synthetic human muscle type adenylate kinase 1 (hAK1) and its mutant (AK1R138A) were re-combinded with E. coli and expressed in M9 cell. Expressed proteins were purified and finally gained at 0.520 mM hAK1 and 0.252 mM AK1R138A. Multinuclear multidimensional NMR experiments including HNCA, HN(CO)CA, were conducted for amino acid sequence analysis and signal assignments of HSQC spectrum. Our chemical shift perturbation data is shown LID domain residues and around alanine[138] and per-turbation value(0.22ppm) of valine[179] is consid-ered as inter-communication effect with LID domain and the structural change between hAK1 and AK1R138A.
 Cited by
P. P. Dzeja, R. J.Zeleznikar, and N. D.Goldberg, Mol. Cel. Biochem. 184, 169 (1998) crossref(new window)

R. J. Zeleznikar, P. P. Dzeja, and N. D.Goldberg, J. Biol. Chem. 270, 7311 (1995) crossref(new window)

A. R.Van Rompay, M. Johansson, and A. Karlsson, Pharm.& Thera. 87, 189 (2000) crossref(new window)

S. Inouye, Y. Yamada, K. Miura, H.Suzuki, K. Kawata, K. Shinoda, and A. Nakazawa, Biochem. biophy. commuications 254, 618 (1999) crossref(new window)

P. Dzeja, and A.Terzic, J. mol. 10, 1729 (2009)

S. Miron, H. Munier-Lehmann, C. T. Craescu, J. Biomol. NMR 19, 89 (2001) crossref(new window)

M. Bellinzoni, A. Haouz, M. Grana, H. Munier-Lehmann, W. Shepard, and P. M. Alzari, Prot. Soc.15, 1489 (2006) crossref(new window)

D. Dreusicke, P. Karplus, and G. Schulz, J. mol. bio. 199, 359 (1988) crossref(new window)

U. Egner, A. Tomasselli, G.Schulz, J. mol. bio. 195, 649 (1987) crossref(new window)

U. Abele, G. E. Schulz, Prot. Soc. 4, 1262 (1995) crossref(new window)

C. Fu, Y. P, X. Liao, C. Guo, and D. Lin, Biomol. NMR Assign. 32, 276 (2012)

A. Abragam., Oxford. Clarendon Press., 1961.

G. Lipari and A. Szabo, J. Am .Chem. Soc. 104, 4546 (1982) crossref(new window)

K. A. Henzler-Wildman, V. Thai, M. Lei, M. Ott, M. Wolf-Watz, T. Fenn, E. Pozharski, M. A.Wilson, G. A. Petsko, M. Karplus, C. G.Hubner, and D. Kern, Nature 450, 838 (2007) crossref(new window)

P. C.Whitford, S. Gosavi, and J. N. Onuchic, J. Biol. Chem. 283, 2042 (2008) crossref(new window)

S. H. Lee, K. H., Y. K. Park, and G. H. Bai, Tuberc. Respir. Dis.60, 187 (2006) crossref(new window)

H. J. Kim, S. Nishikawa, T. Tanaka, S. Uesugi, H. Takenaka, M. Hamada, and S. A. Kuby, Prot. Eng. 2, 379 (1989) crossref(new window)

I. J. Byeon, L. H. Yan et al., Am. Chem. Soc. 32, 12508 (1993)

C. Lee, and H. Won, J. Kor. Mag. Reson., 11, 129 (2007)

D. Kim, and H. Won, J. Kor. Mag. Reson., 2, 50 (1998)

A. M. Calfat, H. Won, and L. G. Marzilli, J. Am. Chem. Soc. 119, 3656 (1997) crossref(new window)